Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRMT1 | Q99873 | 1/20 | 0.54 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | IDO1 | P14902 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | S1PR1 | P21453 | 3/20 | 0.44 |
| ▸ | S1PR3 | Q99500 | 2/20 | 0.44 |
| ▸ | HTR2A | P28223 | 3/20 | 0.43 |
| ▸ | MAOB | P27338 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28725423 | 1.00 | PRMT1 (0.54) | PRMT1RAB9AKDM4EIDO1ALDH1A1 | |
| SCHEMBL29176161 | 0.91 | PRMT1 (0.50) | PRMT1RAB9AKDM4EIDO1ALDH1A1 | |
| SCHEMBL11032133 | 0.91 | PRMT1 (0.50) | PRMT1RAB9AKDM4EIDO1ALDH1A1 | |
| SCHEMBL30694747 | 0.90 | PRMT1 (0.49) | PRMT1RAB9AKDM4EIDO1ALDH1A1 | |
| SCHEMBL28520466 | 0.90 | PRMT1 (0.49) | PRMT1RAB9AKDM4EIDO1ALDH1A1 | |
| SCHEMBL11597357 | 0.88 | PRMT1 (0.55) | PRMT1RAB9AKDM4EIDO1ALDH1A1 | |
| SCHEMBL11597360 | 0.88 | PRMT1 (0.55) | PRMT1RAB9AKDM4EIDO1ALDH1A1 | |
| SCHEMBL2770965 | 0.83 | KDM4E (0.55) | PRMT1RAB9AKDM4EIDO1ALDH1A1 | |
| SCHEMBL2770961 | 0.83 | KDM4E (0.55) | PRMT1RAB9AKDM4EIDO1ALDH1A1 | |
| SCHEMBL3305133 | 0.81 | HDAC3 (0.49) | PRMT1RAB9AKDM4EALDH1A1S1PR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0451753-A1 | In the ethylenic moiety substituted phenylalkylethylenediamine-platinum (II or IV) derivatives and phenylalkyl-ethylenediamines | ASTA Medica Aktiengesellschaft (DE) | 1991-10-16 | — | — | EP | claimed |
| US-20260054913-A1 | CONTACT LENSES HAVING CATIONIC MONOMERS OR CATIONIC POLYMERS FOR RELEASING COMFORT AGENTS | CITIBANK, N.A., AS NOTES COLLATERAL AGENT | 2026-02-26 | — | — | US | disclosed |
| CN-116391140-B | Cationic contact lens | 库博光学国际有限公司 | 2025-01-10 | — | — | CN | disclosed |
| CN-118251617-A | Cationic contact lenses | 库博光学国际有限公司 | 2024-06-25 | — | — | CN | disclosed |
| CN-115668002-B | Contact lenses releasing oleic acid | 库博光学国际有限公司 | 2023-09-15 | — | — | CN | disclosed |
| CN-116391140-A | Cationic contact lens | 库博光学国际有限公司 | 2023-07-04 | — | — | CN | disclosed |
| CN-116376137-A | Polyethylene master batch, preparation method and antistatic polyethylene pipe | 廊坊北化高分子材料有限公司 | 2023-07-04 | — | — | CN | disclosed |
| CN-115668002-A | Oleic acid releasing contact lenses | 库博光学国际有限公司 | 2023-01-31 | — | — | CN | disclosed |
| CN-114230950-A | Semiconductor equipment sealing element and preparation method thereof | 上海芯密科技有限公司 | 2022-03-25 | — | — | CN | disclosed |
| CN-104204294-B | Promote the method for sticky limit between dielectric substrate and metal layer | 德国艾托特克公司 | 2018-12-07 | — | — | CN | disclosed |
| CN-107112311-A | Method for the electromagnetic shielding and heat management of driving component | 德国艾托特克公司 | 2017-08-29 | — | — | CN | disclosed |
| CN-107112224-A | Cabosil chemically-mechanicapolish polishes concentrate | 嘉柏微电子材料股份公司 | 2017-08-29 | — | — | CN | disclosed |
| US-8961831-B2 | Silane-containing pigment particles for electrophoretic display | E INK CALIFORNIA, LLC (US) | 2015-02-24 | — | — | US | disclosed |
| US-20140339480-A1 | SILANE-CONTAINING PIGMENT PARTICLES FOR ELECTROPHORETIC DISPLAY | E INK CORPORATION | 2014-11-20 | — | — | US | disclosed |
| WO-2008026075-A2 | TREATMENT OF INTRACELLULAR BACTERIAL INFECTIONS WITH A PROTEIN KINASE INHIBITOR OR AN AS160 POLYPEPTIDE ACTIVATOR | VERENIGING HET NEDERLANDS KANKER INSTITUUT (NL) | 2008-03-06 | — | — | WO | disclosed |
| US-5238955-A | Anticarcinogenic agents | ASTA PHARMA AG (DE) | 1993-08-24 | — | — | US | disclosed |
| US-5238955-A | Anticarcinogenic agents | ASTA PHARMA AG (DE) | 1993-08-24 | — | — | US | disclosed |
| US-5194644-A | Antitumor agents; treatment of leukemia | ASTA PHARMA AG (DE) | 1993-03-16 | — | — | US | disclosed |
| EP-0451753-A1 | In the ethylenic moiety substituted phenylalkylethylenediamine-platinum (II or IV) derivatives and phenylalkyl-ethylenediamines | ASTA Medica Aktiengesellschaft (DE) | 1991-10-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260054913-A1 | CONTACT LENSES HAVING CATIONIC MONOMERS OR CATIONIC POLYMERS FOR RELEASING COMFORT AGENTS | TRPA1, ASIC1, ARGLU1 | PRMT1 1489/4885RAB9A 2294/4885KDM4E 2339/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.